These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34757990)

  • 1. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
    Sevelius JM; Glidden DV; Deutsch M; Welborn L; Contreras A; Salinas A; Venegas L; Grant RM
    J Acquir Immune Defic Syndr; 2021 Dec; 88(S1):S27-S38. PubMed ID: 34757990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
    Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
    J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitators of PrEP Persistence among Black and Latinx Transgender Women in a PrEP Demonstration Project in Southern California.
    Storholm ED; Ogunbajo A; Nacht CL; Opalo C; Horvath KJ; Lyman P; Flynn R; Reback CJ; Blumenthal J; Moore DJ; Bolan R; Morris S
    Behav Med; 2024; 50(1):63-74. PubMed ID: 35993278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study.
    Jalil EM; Torres TS; Luz PM; Monteiro L; Moreira RI; de Castro CRV; Leite IDC; Cunha M; de Cássia Elias Estrela R; Ramos M; Hoagland B; Wagner Cardoso S; Anderson P; Veloso VG; Wilson E; Grinsztejn B;
    J Int AIDS Soc; 2022 Mar; 25(3):e25896. PubMed ID: 35255199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-Based Violence and Post-traumatic Stress Disorder Symptoms Predict HIV PrEP Uptake and Persistence Failure Among Transgender and Non-binary Persons Participating in a PrEP Demonstration Project in Southern California.
    Storholm ED; Huang W; Ogunbajo A; Horvath KJ; Reback CJ; Blumenthal J; Moore DJ; Flynn RP; Bolan RK; Corado KC; Morris SR
    AIDS Behav; 2023 Feb; 27(2):745-759. PubMed ID: 36053404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
    Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
    AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United States.
    Chan PA; Patel RR; Mena L; Marshall BD; Rose J; Sutten Coats C; Montgomery MC; Tao J; Sosnowy C; Mayer KH; Nunn A
    J Int AIDS Soc; 2019 Aug; 22(8):e25385. PubMed ID: 31423756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam.
    Hoornenborg E; Achterbergh RC; van der Loeff MFS; Davidovich U; van der Helm JJ; Hogewoning A; van Duijnhoven YT; Sonder GJ; de Vries HJ; Prins M;
    J Int AIDS Soc; 2018 Mar; 21(3):e25105. PubMed ID: 29603900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV.
    Anderson KM; Blumenthal J; Jain S; Sun X; Amico KR; Landovitz R; Zachek CM; Morris S; Moore DJ; Stockman JK
    BMC Public Health; 2024 May; 24(1):1461. PubMed ID: 38822300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
    Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
    PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial.
    Kawichai S; Songtaweesin WN; Wongharn P; Phanuphak N; Cressey TR; Moonwong J; Vasinonta A; Saisaengjan C; Chinbunchorn T; Puthanakit T
    JMIR Mhealth Uhealth; 2022 Apr; 10(4):e25561. PubMed ID: 35451976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to Daily Oral TDF/FTC for PrEP in Community Health Center Populations: The Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study.
    Smith DK; Rawlings MK; Glick N; Mena L; Coleman M; Houlberg M; McCallister S; Wiener J
    AIDS Behav; 2022 Feb; 26(2):350-360. PubMed ID: 34347198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrEP Use and Adherence among Transgender Persons in Chicago, IL (SHIPP Study, 2014-2018, USA).
    Townes A; Pyra M; Smith DK; Babu AS; Williams T; Wiener J; Henny KD; Schneider J
    AIDS Behav; 2023 Mar; 27(3):901-908. PubMed ID: 36094640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providing HIV pre-exposure prophylaxis to men who have sex with men and transgender women in hospitals and community-led clinics in Thailand: acceptance, patterns of use, trends in risk behaviors, and HIV incidence.
    L C; M C; P N; T D; K T; P T; P S; P P; V P; J S; L D; N T; J N; M M
    AIDS Care; 2023 Apr; 35(4):524-537. PubMed ID: 36726288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.